Cancer Research UK Cancer Awareness Measures, 2019: Special Licence Access

Name: Cancer Research UK Cancer Awareness Measures, 2019: Special Licence Access
Creator: UK Data Service
Published: 2024-11-29 07:24:52
License: 暂无描述

CESSDA2024-11-29 更新2024-08-10 收录

下载链接：

https://datacatalogue.cessda.eu/detail?lang=en&q=e4b81b833b60a29f2af3e054922b3ad41ca8279298f764d5604ee51b4f5b7224

下载链接

链接失效反馈

官方服务：

资源简介：

Abstract copyright UK Data Service and data collection copyright owner.The Cancer Awareness Measure (CAM) was developed in 2007-8 to address the absence of a validated measure of general public awareness of cancer (Stubbings, S., Robb, K., Waller, J., Ramirez, A., Austoker, J., Macleod, U., Hion, S., and Wardle, J. (2009) 'Development of a measurement tool to assess public awareness of cancer', British Journal of Cancer, 101(2), S13-S17.).The survey includes measures of awareness of signs and symptoms of cancer, cancer risk factors, age-related risk, screening programmes and potential barriers to seeing the GP. Since then, Cancer Research UK (CRUK) has significantly revised and updated the survey, including a wider range of questions and collecting data online instead of face-to-face.  The Cancer Awareness Measure (CAM) is a survey designed to assess public awareness of cancer warning signs/symptoms, cancer risk factors and barriers to help seeking. Data have been collected every two years from 2008 to 2017 from a representative face to face sample of the population of Great Britain via the Office of National Statistics (ONS) <a title="Opinions and Lifestyle Survey" href="https://beta.ukdataservice.ac.uk/datacatalogue/series/series?id=2000043">Opinions and Lifestyle Survey</a>. The 2019 survey was conducted online using a GB representative sample (3,044 adults) from Trinity McQueen.Patients with cancer in the UK tend to present with more advanced disease and have poorer survival rates than their European counterparts. One of the work streams set out in the National Awareness and Early Diagnosis Initiative (NAEDI), which was established under the Department of Health's Cancer Reform Strategy for improving cancer outcomes, has focused on developing a validated standardised measure for the general population, comprising a set of questions designed to reliably assess cancer awareness.The purpose of the Cancer Awareness Measure (CAM) is to facilitate accurate and sensitive surveillance of public awareness of cancer over time, identify information needs, and monitor the impact of campaigns promoting cancer awareness and early presentation. It helps to develop an in-depth understanding of current awareness, attitudes, beliefs and behaviours in relation to cancer.Further information about the CAM may be found on the Cancer Research UK <a title="Cancer Research UK Cancer Awareness Measures (CAMs)" href="https://www.cancerresearchuk.org/health-professional/awareness-and-prevention/the-cancer-awareness-measures-cam#CAM_Use3">Cancer Awareness Measures (CAMs)</a> webpage. Main Topics: <div class="x_x_OutlineElement x_x_Ltr x_x_SCXW160662473 x_x_BCX0">The CAM questionnaires address the following topics: </div><ul></ul><ul><li>public awareness of cancer symptoms </li><li>public knowledge of cancer risk factors </li><li>barriers and enablers to help seeking </li><li>uptake of screening programmes </li><li>barriers to cancer screening (cervical, breast and bowel)</li><li>experience of breast and cervical cancer screening </li><li>symptom experience </li><li>co-morbidities</li><li>perception of symptom seriousness </li><li>help seeking behaviours including remote consultation and re-presentation </li><li>perceptions of remote consultation </li><li>demographic variables including health behaviours such as smoking and fruit and vegetable consumption.</li></ul><ul><ul></ul></ul>From 2021 onwards, the questionnaire also covers:<ul><li>impact of COVID-19 on help seeking behaviour</li><li>perceptions of safety from COVID-19 in different medical settings.</li></ul>The Special Licence version of the CAM dataset includes more detailed data on symptoms, risk factors and reasons for delay. Users should check the standard End User Licence (EUL) version of the study to see whether it meets their research needs before making an application for the Special Licence version.

提供机构：

UK Data Service

创建时间：

2021-03-10